Skip to main content

One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.

Imbruvica seemed invincible in the marketplace. But a new book, “For Blood and Money,” shows how the drug’s creators left a trap door that led to its undoing.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.